551 related articles for article (PubMed ID: 31801553)
1. Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer's disease.
Jia L; Piña-Crespo J; Li Y
Mol Brain; 2019 Dec; 12(1):104. PubMed ID: 31801553
[TBL] [Abstract][Full Text] [Related]
2. TGF-β1 Restores Hippocampal Synaptic Plasticity and Memory in Alzheimer Model via the PI3K/Akt/Wnt/β-Catenin Signaling Pathway.
Hu Y; Chen W; Wu L; Jiang L; Liang N; Tan L; Liang M; Tang N
J Mol Neurosci; 2019 Jan; 67(1):142-149. PubMed ID: 30539409
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of CXXC5 function rescues Alzheimer's disease phenotypes by restoring Wnt/β-catenin signaling pathway.
Yoon M; Kim H; Shin H; Lee H; Kang MJ; Park SH; Han G; Kim Y; Choi KY
Pharmacol Res; 2023 Aug; 194():106836. PubMed ID: 37355147
[TBL] [Abstract][Full Text] [Related]
4. Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease.
Liu L; Wan W; Xia S; Kalionis B; Li Y
Neurochem Int; 2014 Sep; 75():19-25. PubMed ID: 24859746
[TBL] [Abstract][Full Text] [Related]
5. Molecular Insights to the Wnt Signaling During Alzheimer's Disorder: a Potential Target for Therapeutic Interventions.
Nagu P; Sharma V; Behl T; Pathan AKA; Mehta V
J Mol Neurosci; 2022 Apr; 72(4):679-690. PubMed ID: 34997460
[TBL] [Abstract][Full Text] [Related]
6. Impaired Wnt Signaling in the Prefrontal Cortex of Alzheimer's Disease.
Folke J; Pakkenberg B; Brudek T
Mol Neurobiol; 2019 Feb; 56(2):873-891. PubMed ID: 29804228
[TBL] [Abstract][Full Text] [Related]
7. Sodium selenate activated Wnt/β-catenin signaling and repressed amyloid-β formation in a triple transgenic mouse model of Alzheimer's disease.
Jin N; Zhu H; Liang X; Huang W; Xie Q; Xiao P; Ni J; Liu Q
Exp Neurol; 2017 Nov; 297():36-49. PubMed ID: 28711506
[TBL] [Abstract][Full Text] [Related]
8. Icarisid II rescues cognitive dysfunction via activation of Wnt/β-catenin signaling pathway promoting hippocampal neurogenesis in APP/PS1 transgenic mice.
Xiao HH; Chen JC; Li H; Li RH; Wang HB; Song HP; Li HY; Shan GS; Tian Y; Zhao YM; Tian JM; Yang JX
Phytother Res; 2022 May; 36(5):2095-2108. PubMed ID: 35230733
[TBL] [Abstract][Full Text] [Related]
9. Selenomethionine promoted hippocampal neurogenesis via the PI3K-Akt-GSK3β-Wnt pathway in a mouse model of Alzheimer's disease.
Zheng R; Zhang ZH; Chen C; Chen Y; Jia SZ; Liu Q; Ni JZ; Song GL
Biochem Biophys Res Commun; 2017 Mar; 485(1):6-15. PubMed ID: 28109879
[TBL] [Abstract][Full Text] [Related]
10. WNT Signaling Is a Key Player in Alzheimer's Disease.
Inestrosa NC; Tapia-Rojas C; Cerpa W; Cisternas P; Zolezzi JM
Handb Exp Pharmacol; 2021; 269():357-382. PubMed ID: 34486097
[TBL] [Abstract][Full Text] [Related]
11. Neural Stem Cells Secretome Increased Neurogenesis and Behavioral Performance and the Activation of Wnt/β-Catenin Signaling Pathway in Mouse Model of Alzheimer's Disease.
Hijroudi F; Rahbarghazi R; Sadigh-Eteghad S; Bahlakeh G; Hassanpour M; Shimia M; Karimipour M
Neuromolecular Med; 2022 Dec; 24(4):424-436. PubMed ID: 35576045
[TBL] [Abstract][Full Text] [Related]
12. Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease.
Fuentealba RA; Farias G; Scheu J; Bronfman M; Marzolo MP; Inestrosa NC
Brain Res Brain Res Rev; 2004 Dec; 47(1-3):275-89. PubMed ID: 15572177
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of canonical Wnt signaling in hippocampus of SAMP8 mice.
Bayod S; Felice P; Andrés P; Rosa P; Camins A; Pallàs M; Canudas AM
Neurobiol Aging; 2015 Feb; 36(2):720-9. PubMed ID: 25443287
[TBL] [Abstract][Full Text] [Related]
14. Activation of Wnt/β-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease.
Wang Q; Huang X; Su Y; Yin G; Wang S; Yu B; Li H; Qi J; Chen H; Zeng W; Zhang K; Verkhratsky A; Niu J; Yi C
Brain; 2022 Dec; 145(12):4474-4488. PubMed ID: 35788280
[TBL] [Abstract][Full Text] [Related]
15. Wnt signaling in Alzheimer's disease: up or down, that is the question.
Boonen RA; van Tijn P; Zivkovic D
Ageing Res Rev; 2009 Apr; 8(2):71-82. PubMed ID: 19101658
[TBL] [Abstract][Full Text] [Related]
16. Wnt/β-catenin signaling in Alzheimer's disease.
De Ferrari GV; Avila ME; Medina MA; Perez-Palma E; Bustos BI; Alarcon MA
CNS Neurol Disord Drug Targets; 2014; 13(5):745-54. PubMed ID: 24365184
[TBL] [Abstract][Full Text] [Related]
17. Osthole promotes neuronal differentiation and inhibits apoptosis via Wnt/β-catenin signaling in an Alzheimer's disease model.
Yao Y; Gao Z; Liang W; Kong L; Jiao Y; Li S; Tao Z; Yan Y; Yang J
Toxicol Appl Pharmacol; 2015 Dec; 289(3):474-81. PubMed ID: 26525509
[TBL] [Abstract][Full Text] [Related]
18. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
Tapia-Rojas C; Inestrosa NC
J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer's disease.
Riise J; Plath N; Pakkenberg B; Parachikova A
J Neural Transm (Vienna); 2015 Sep; 122(9):1303-18. PubMed ID: 25680440
[TBL] [Abstract][Full Text] [Related]
20. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
